Tonix Pharmaceuticals (TNXP)
(Delayed Data from NSDQ)
$0.33 USD
+0.01 (3.89%)
Updated Mar 18, 2024 04:00 PM ET
Pre-Market: $0.35 +0.02 (4.95%) 9:26 AM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
Estimates
Exp Earnings Date | 3/25/24 |
---|---|
Current Quarter | -1.55 |
EPS Last Quarter | -1.83 |
Last EPS Surprise | -22.82% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -8.38 |
Next Year | -4.26 |
EPS (TTM) | -11.26 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.95M | 4.30M | 7.95M | 18.05M |
# of Estimates | 2 | 1 | 2 | 2 |
High Estimate | 4.00M | 4.30M | 8.00M | 18.10M |
Low Estimate | 3.90M | 4.30M | 7.89M | 18.00M |
Year ago Sales | 0.00M | 0.00M | NA | 7.95M |
Year over Year Growth Est. | NA | NA | NA | 127.19% |
Earnings Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.55 | -0.14 | -8.38 | -4.26 |
# of Estimates | 2 | 1 | 2 | 2 |
Most Recent Consensus | -1.46 | -0.14 | -7.96 | -5.83 |
High Estimate | -1.46 | -0.14 | -7.96 | -2.69 |
Low Estimate | -1.64 | -0.14 | -8.80 | -5.83 |
Year ago EPS | -3.50 | -3.25 | -20.44 | -8.38 |
Year over Year Growth Est. | 55.71% | 95.69% | 59.00% | 49.16% |
Agreement - Estimate Revisions
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | -1.55 | -0.14 | -8.38 | -4.26 |
7 Days Ago | -1.46 | -0.62 | -8.37 | -4.26 |
30 Days Ago | -1.46 | -0.62 | -8.37 | -4.26 |
60 Days Ago | -1.46 | -0.62 | -8.37 | -4.26 |
90 Days Ago | -1.46 | -0.62 | -8.37 | -4.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.55 | -0.14 | -8.38 | -4.26 |
Zacks Consensus Estimate | -1.55 | -0.14 | -8.38 | -4.26 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.83 | -2.68 | -3.25 | -3.50 | NA |
Estimate | -1.49 | -2.78 | -2.50 | -3.94 | NA |
Difference | -0.34 | 0.10 | -0.75 | 0.44 | -0.14 |
Surprise | -22.82% | 3.60% | -30.00% | 11.11% | -9.53% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more